Ironwood Pharmaceuticals
IRWD
IRWD
195 hedge funds and large institutions have $2.36B invested in Ironwood Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 53 increasing their positions, 69 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2.13% more ownership
Funds ownership: 111.03% → 113.16% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 69
Holders
195
Holding in Top 10
3
Calls
$11.3M
Puts
$8.93M
Top Buyers
| 1 | +$13.6M | |
| 2 | +$13.2M | |
| 3 | +$11.8M | |
| 4 |
D.E. Shaw & Co
New York
|
+$10.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.32M |
Top Sellers
| 1 | -$25.5M | |
| 2 | -$16.9M | |
| 3 | -$8.44M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.2M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$5.53M |